Uncommon Sample Clauses

Uncommon. Alopecia; depression; dyspnoea; myalgia; photosensitivity reaction; thrombocytopenia Rare or very rare • Agranulocytosis; bone marrow disorders; cardiac inflammation; hepatitis; neutropenia; pancreatitis; peripheral neuropathy; renal impairment; respiratory disorders Frequency not known • Angioedema; eosinophilia; haemolytic anaemia; nephritis tubulointerstitial; oligozoospermia (reversible); ulcerative colitis aggravated Common drug interactions For a comprehensive list of interactions see the BNF or product SPC. Patients receiving hypoglycemic agents and sulfasalazine should be closely monitored. Azathiopurine and sulfasalazine should not be co-prescribed. Reduced absorption of digoxin occurred with co-administration. Pregnancy and breastfeeding and Contraception Sulfasalazine can be prescribed in pregnant or breastfeeding patients. In these instances, prescribing should remain with the consultant. In breastfeeding children small amounts of sulfasalazine are secreted in breastmilk. Patients should avoid breastfeeding while taking this medicine. Vaccinations Consultants should identify patients requiring immunisation in line with JCVI recommendations. Once administered the primary care prescriber will provide written confirmation that the vaccine has been administered then treatment will be commenced. Annual flu vaccines are recommended. Check patient has had ONE DOSE of pneumococcal vaccine. Additional doses are not routinely recommended. Low levels of immunosuppression are not absolute contraindication to the use of live vaccines, these should be discussed with a specialist on a case by case basis. All patients which are immunosuppressed due to a conventional DMARD should be encouraged to receive a COVID-19 vaccine, regardless of treatment regimen or underlying diagnosis. The benefits of the COVID-19 vaccination outweigh the risks and by having the vaccine, they reduce the risk of developing severe complications due to COVID-19. Some may have a sub-optimal response. If there is any uncertainty regarding advice to give patients please contact the Rheumatology team at RJAH on the contact details below. The Joint Committee of Vaccination and Immunisation (JCVI) hasn't advised a vaccine preference for any specific population, advising that all give very high protection against severe disease and have good safety profiles. This information on COVID-19 vaccinations is under constant review. The latest updated information can be found in The Green book. Monito...
AutoNDA by SimpleDocs
Uncommon. Aggression, cold extremities, emotional lability, hostility, hypoaesthesia, menstrual disturbances, muscle spasms, pruritus, psychosis, QT-interval prolongation, suicidal ideation, syncope and tics. Rare Xxxxxxx’s phenomenon and seizures. Very Rare Angle-closure glaucoma and hepatic disorders For other adverse effects refer to current Summary of Product Characteristics (SPC): xxx.xxxxxxxxx.xxx.xx or British National Formulary for Children (BNFC), available at xxx.xxx.xxx Drug interactions Refer to current Summary of Product Characteristics (SPC): xxx.xxxxxxxxx.xxx.xx or British National Formulary for Children (BNFC), available at xxx.xxx.xxx GP RESPONSE FOLLOWING REQUEST FOR SUPPORT WITH REPEAT PRESCRIBING Dear doctor, Patient (Insert patient’s name) Identifier (CHI/address) I have received your request for shared care of this patient who has been advised to continue (Atomoxetine). I have read the Atomoxetine Shared Care Agreement. Please circle a response A) I am willing to prescribe Atomoxetine and adhere to the terms in this Shared Care Agreement.
Uncommon. Aggression, cold extremities, emotional lability, hostility, hypoaesthesia, menstrual disturbances, muscle spasms, pruritus, psychosis, QT-interval prolongation, suicidal ideation, syncope and tics. Rare Xxxxxxx’s phenomenon and seizures. Very Rare Angle-closure glaucoma and hepatic disorders Monitoring Monitoring of height, weight, blood pressure, pulse and psychiatric symptoms is carried out by the specialist service during initiation, at the initial 3-month review and subsequently at 6-monthly reviews. If results are out with the expected range there will be liaison with the GP about any changes, further investigations and referral to the specialist service if required. Cautions, contraindications - Refer to current Summary of Product Characteristics (SPC): xxx.xxxxxxxxx.xxx.xx Adverse effects - Refer to current Summary of Product Characteristics (SPC): xxx.xxxxxxxxx.xxx.xx Drug interactions - Refer to current Summary of Product Characteristics (SPC): xxx.xxxxxxxxx.xxx.xx Atomoxetine Shared Care Agreement
Uncommon. Anaemia; anxiety; electrolyte imbalance; hyperlipidaemia; taste altered; thrombocytopenia Rare or very rare Agranulocytosis; eosinophilia; hepatic disorders; infection; pancreatitis; pancytopenia; respiratory disorders; sepsis; severe cutaneous adverse reactions (SCARs); vasculitis Frequency not known Cutaneous lupus erythematosus; hypouricaemia; pulmonary hypertension; renal failure Common drug interactions For a comprehensive list of interactions see the BNF or product SPC. Leflunomide has an extremely long half-life and interactions may occur even after leflunomide has been discontinued. Leflunomide may inhibit the metabolism of warfarin, phenytoin and tolbutamide. The effect of leflunomide is decreased by cholestyramine. This should be avoided unless this effect is desired. Pregnancy and breastfeeding and Contraception This drug should not be prescribed during pregnancy or while breastfeeding. It is important that women of childbearing potential do not start leflunomide until pregnancy has been excluded. Effective contraception essential during treatment and for at least 2 years after treatment in women and at least 3 months after treatment in men (plasma concentration monitoring required; waiting time before conception may be reduced with washout procedure—consult product literature). If there is a delay in onset of menstruation or other reason to suspect pregnancy then the patient much notify their primary care prescriber and consultant as soon as possible. If the patient wants to conceive then blood metabolite levels need to be checked and a wash out organised as specified in product literature if necessary.

Related to Uncommon

  • Infrastructure (a) The Borrower has and will maintain a sufficient infrastructure to conduct its business as presently conducted and as contemplated to be conducted following its execution of this Agreement.

  • Unbundled Loops 2.1.1 BellSouth agrees to offer access to unbundled loops pursuant to the following terms and conditions and at the rates set forth in Attachment 11.

  • Classroom Management The certificated classroom teacher demonstrates in his/her performance a competent level of knowledge and skill in organizing the physical and human elements in the educational setting.

  • Remote Terminal Unit Prior to the Initial Synchronization Date of the Large Generating Facility, a Remote Terminal Unit, or equivalent data collection and transfer equipment acceptable to the Parties, shall be installed by Developer, or by Connecting Transmission Owner at Developer’s expense, to gather accumulated and instantaneous data to be telemetered to the location(s) designated by Connecting Transmission Owner and NYISO through use of a dedicated point-to-point data circuit(s) as indicated in Article 8.1. The communication protocol for the data circuit(s) shall be specified by Connecting Transmission Owner and NYISO. Instantaneous bi-directional analog real power and reactive power flow information must be telemetered directly to the location(s) specified by Connecting Transmission Owner and NYISO. Each Party will promptly advise the appropriate other Party if it detects or otherwise learns of any metering, telemetry or communications equipment errors or malfunctions that require the attention and/or correction by that other Party. The Party owning such equipment shall correct such error or malfunction as soon as reasonably feasible.

  • Dewatering 4.7.1 Where a part of a site is affected by surface water following a period of rain, thus rendering some areas unsafe for productive work, consistent with the Employer’s obligations under the OH&S Act, all non- trades employees shall assist in ‘dewatering’ their own work site or area if it is so affected. Such work to be paid at single time rates. Productive work will continue in areas not so affected.

  • TOOL STORAGE 1. A company shall provide on all construction jobs in towns and cities, and elsewhere where reasonably necessary and practicable (or if requested buy the employee), a suitable and secure waterproof lock-up solely for the purpose of storing employees’ tools, and on multi-storey and major projects the company shall provide, where possible, a suitable lock-up for employees’ tools within a reasonable distance of the work area of large groups of employees.

  • Unbundled Network Elements 35.4.1. The charges that CLEC shall pay to Sprint for Unbundled Network Elements are set forth in Table One of this Agreement. 35.5. Collocation

  • Automobiles The Company shall provide Executive with an automobile allowance of $500 per month, consistent with the practices of the Company.

  • Shopping Goods and works estimated to cost less than $100,000 equivalent per contract may be procured under contracts awarded on the basis of Shopping.

  • Trading facilities Most open-outcry and electronic trading facilities are supported by computer-based component systems for the order-routing, execution, matching, registration or clearing of trades. As with all facilities and systems, they are vulnerable to temporary disruption or failure. Your ability to recover certain losses may be subject to limits on liability imposed by the system provider, the market, the clearing house and/or member firms. Such limits may vary; you should ask the firm with which you deal for details in this respect.

Time is Money Join Law Insider Premium to draft better contracts faster.